Type 1 diabetes rates are rising, but breakthrough drugs and devices are changing what it means to live with the disease.

More information: Viral N. Shah et al, Semaglutide in Adults with Type 1 Diabetes and Obesity, NEJM Evidence (2025). DOI: 10.1056/EVIDoa2500173 Provided by Oregon Health & Science University ...

CHICAGO — Once-weekly semaglutide improved glycemia and reduced weight without increasing hypoglycemia in adults with type 1 diabetes (T1D) and obesity, new research presented at the American ...

Advanced technology has boosted the ability of children and adults to manage their type 1 diabetes, a new study says.

The cost-effectiveness of the drug for NHS roll-out will now be assessed by the National Institute for Health and Care Excellence.